Real World Outcomes of Immunotherapy (IO) for Pleural MESOthelioma in Australia - RIOMeso

被引：0
|
作者：
McNamee, N. [1 ,2 ,3 ]
Harvey, C. [2 ]
Gray, L. [2 ]
Khoo, T. [4 ]
Lingam, L. [5 ]
Zhang, B. [6 ]
Clay, T. [7 ,8 ]
Arulananda, S. [9 ,10 ]
Itchins, M. [11 ,12 ]
Pavlakis, N. [11 ,12 ,13 ]
Kao, S. [12 ]
Bowyer, S. [13 ]
Chin, V. [14 ]
Warburton, L.
da Silva, I. [15 ]
John, T. [16 ]
Solomon, B. [16 ]
Alexander, M. [16 ,17 ]
Nagrial, A. [2 ,15 ]
机构：
[1] Kinghorn Canc Ctr, Sydney, NSW, Australia
[2] Westmead Hosp, Sydney, NSW, Australia
[3] Garvan Inst Med Res, Sydney, NSW, Australia
[4] Sir Charles Gairdner Hosp, Perth, WA, Australia
[5] Fiona Stanley Hosp, Perth, WA, Australia
[6] Chris OBrien Lifehouse, Sydney, NSW, Australia
[7] St John God Subiaco, Perth, WA, Australia
[8] Edith Cowan Univ, Perth, WA, Australia
[9] Monash Hlth, Melbourne, Vic, Australia
[10] Monash Univ, Melbourne, Vic, Australia
[11] Royal North Shore Hosp, Sydney, NSW, Australia
[12] Univ Sydney, Sydney, NSW, Australia
[13] Univ Western Australia, Perth, WA, Australia
[14] Univ New South Wales, Sydney, NSW, Australia
[15] Blacktown Hosp, Sydney, NSW, Australia
[16] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[17] Univ Melbourne, Melbourne, Vic, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
mesothelioma; immunotherapy; real-world;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA17.05
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [31] Pembrolizumab (pembro) for relapsed malignant pleural mesothelioma (MPM): Outcomes in real-life setting in Australia (AUS) and Switzerland (CH)
    Mauti, L.
    Rivalland, G.
    Klingbiel, D.
    Kao, S.
    Schmid, S.
    Nowak, A.
    Gautschi, O.
    Hughes, B.
    Bartnick, T.
    Pavlakis, N.
    Bouchaab, H.
    O'Byrne, K.
    Rothschild, S.
    Russell, P.
    Prince, S. Savic
    Thapa, B.
    Pless, M.
    Von Moos, R.
    Metaxas, Y.
    John, T.
    ANNALS OF ONCOLOGY, 2017, 28 : 8 - 8
  • [32] RADIOLOGY OF MALIGNANT PLEURAL MESOTHELIOMA IN WESTERN AUSTRALIA
    LANGLOIS, SL
    GLANCY, JJ
    HENDERSON, DW
    AUSTRALASIAN RADIOLOGY, 1978, 22 (04): : 305 - 314
  • [33] Real-world outcomes of pembrolizumab in peritoneal mesothelioma.
    Marmarelis, Melina Elpi
    Wang, Xiao
    Roshkovan, Leonid
    Walker, Suzanne
    McNulty, Sally
    Ciunci, Christine Agnes
    Muira, John
    Katz, Sharyn, I
    Cengel, Keith A.
    Karakousis, Giorgos
    Langer, Corey J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Real-world treatments and clinical outcomes in advanced NSCLC without actionable mutations after introduction of immunotherapy (IO) in Japan
    Nokihara, H.
    Santorelli, M. L.
    Taniguchi, K.
    Kamitani, T.
    Irisawa, M.
    Kanda, K.
    Abe, M.
    Burke, T.
    Goto, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S1014 - S1014
  • [35] Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
    Gray, Steven G.
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [36] Anti-tumor immunotherapy in malignant pleural mesothelioma
    Scherpereel, A.
    Willemin, M. -C.
    Wasielewski, E.
    Dhalluin, X.
    REVUE DES MALADIES RESPIRATOIRES, 2018, 35 (04) : 465 - 476
  • [37] New horizons from immunotherapy in malignant pleural mesothelioma
    Calabro, Luana
    Rossi, Giulia
    Maio, Michele
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S322 - S332
  • [38] Novel immunotherapy clinical trials in malignant pleural mesothelioma
    Tano, Zachary E.
    Chintala, Navin K.
    Li, Xiaoyu
    Adusumilli, Prasad S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (11)
  • [39] Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
    Steven G. Gray
    BMC Pulmonary Medicine, 21
  • [40] Improvement of Malignant Pleural Mesothelioma Immunotherapy by Epigenetic Modulators
    Hamaidia, Malik
    Staumont, Bernard
    Duysinx, Bernard
    Louis, Renaud
    Willems, Luc
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (07) : 777 - 787
12345